PD-L1 expression by itself without checkpoint inhibition appears to be a bad prognostic marker; PD-L1 expression has been found in meta-analyses to be a negative prognostic marker such as in non-small cell lung [22], breast [23] cancer and in an analysis across cancer types [24]. This evidence concerns the gene CD274 and cancer.